Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Forte Biosciences Inc (FBRX)

34.51   1.74 (5.31%) 10-24 00:12
Open: 33.05 Pre. Close: 32.77
High: 36.525 Low: 32.42
Volume: 51,588 Market Cap: 387M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 36.615 - 36.858 36.858 - 37.077
Low: 31.873 - 32.155 32.155 - 32.41
Close: 34.054 - 34.519 34.519 - 34.939

Technical analysis

as of: 2020-10-23 4:43:35 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 53.44     One year: 63.06
Support: Support1: 32.42    Support2: 26.97
Resistance: Resistance1: 45.75    Resistance2: 53.99
Pivot: 39.72
Moving Average: MA(5): 34.26     MA(20): 41.71
MA(100): 27.10     MA(250): 19.49
MACD: MACD(12,26): -1.38     Signal(9): 0.26
Stochastic oscillator: %K(14,3): 4.85     %D(3): 4.02
RSI: RSI(14): 40.89
52-week: High: 53.99  Low: 6.33  Change(%): 220.9
Average Vol(K): 3-Month: 7915  10-Days: 5641

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
FBRX has closed above bottom band by 23.6%. Bollinger Bands are 77.8% wider than normal. The large width of the bands suggest high volatility as compared to FBRX's normal range. The bands have been in this wide range for 6 bars. This is a sign that the current trend might continue.

Headline News

Wed, 21 Oct 2020
Do Insiders Own Lots Of Shares In Forte Biosciences, Inc. (NASDAQ:FBRX)? - Simply Wall St

Fri, 16 Oct 2020
Forte Biosciences, Inc. Reports Inducement Grants Under NASDAQ Listing Rules - Valdosta Daily Times

Tue, 29 Sep 2020
Forte Biosciences (FBRX) Gets a Buy Rating from Ladenburg Thalmann & Co. - Smarter Analyst

Tue, 29 Sep 2020
Forte Biosciences, Inc. Announces First Patient Dosed in the Clinical Trial of FB-401 for the Treatment of Children and Adults With Atopic Dermatitis | DNA RNA and Cells | News Channels -

Wed, 09 Sep 2020
Forte Biosciences, Inc. Announces Full Publication of Phase 1/2 Data in Science Translational Medicine - Business Wire

Fri, 28 Aug 2020
Brookline and Chardan bullish on Forte Biosciences - Seeking Alpha

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Shares Out. (M) 11
Shares Float (M) 3
% Held by Insiders
% Held by Institutions
Shares Short (K) 124
Shares Short P. Month (K) 100

Stock Financials

EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -8
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales
Price to Cash Flow -47.78

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.